Biological Safety Testing Market size is projected to grow at a CAGR of 12.4% to reach USD 11.2 billion by 3030

The Market Statsville Group (MSG) publishes the new report on the "Biological Safety Testing Market by Product (Reagents & Kits, Services, and Instruments), by Test (Sterility Tests, Cell Line Authentication & Characterization Tests, Bioburden Tests, Endotoxin Tests, Residual Host Contamination Detection Tests, Adventitious Agent Detection Tests, and Others), by Application (Tissue & Tissue-Based Products, Stem Cell, Gene Therapy, Blood & Blood-Based Products, and Vaccines & Therapeutics), by Region - Global Share and Forecast to 2030".

Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/biological-safety-testing-market

The global biological safety testing market size is projected to grow at a CAGR of 12.4% to reach USD 11.2 billion by 3030 from USD 4.4 billion in 2021. The biological safety testing market is predominantly driven by the increasing influx of biologics, raising the requirements for highly efficient biological safety testing tools. The results mentioned above from biomanufacturing projects by companies such as Bristol-Myers Squibb, Boehringer Ingelheim, and Astra Zeneca, thus widening the adoption rate for safety testing tools. Moreover, Increasing R&D investments by prominent companies and culminating research costs is presumed to encourage the companies to adopt highly efficient biological testing tools in order to counter possible losses.

Global Biological Safety Testing Market Segmentation
The overall biological safety testing market has been segmented into the component, waste type, method, application, and region.

Direct Purchase Report: https://www.marketstatsville.com/buy-now/biological-safety-testing-market?opt=2950

By Product (Reagents & Kits, Services, and Instruments)
By Test (Sterility Tests, Cell Line Authentication & Characterization Tests, Bioburden Tests, Endotoxin Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, and Others)
By Application (Stem Cell, Tissue & Tissue-Based Products, Gene Therapy, Blood & Blood-Based Products, and Vaccines & Therapeutics)
By Region (US, Canada, Mexico, UK, Germany, France, Italy, Spain, China, Japan, India, South Korea, Southeast Asia, Australia, Saudi Arabia, UAE, South Africa, Qatar, Nigeria, Israel, Brazil, Argentina, Peru)
Endotoxin, by test, hold the largest market share during the forecast period

Based on the test, the market is segmented into sterility tests, cell line authentication & characterization tests, endotoxin tests, adventitious agent detection tests, bioburden tests, residual host contamination detection tests, and others. Endotoxin tests dominated the overall market in terms of revenue in 2021 at 26.5%. The substantial share can be attributed to the high incorporation of these tests in a wide range of drug manufacturing and production areas to reduce the threat of endotoxins during the manufacturing process of biopharmaceuticals.

In addition, the availability of numerous types of endotoxin tests, such as gel clot endotoxin testing, turbidimetric method, and USP chromogenic endotoxin testing, that are designed to suit differing requirements, are presumed to be responsible for the high growth potential in this segment. Moreover, the presence of major healthcare organizations consistently striving to promote awareness and utilization of these tests are held responsible for the significant share held by this segment.

Access full Report Description, TOC, Table of Figure, Chart, etc: https://www.marketstatsville.com/table-of-content/biological-safety-testing-market

North America accounts for the largest market share in 2021

Based on the regions, the global biological safety testing market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2021 had the largest market share of 35.1% in the global biological safety testing market. The share attained by this region is primarily a consequence of the presence of prominent market players undertaking extensive growth expansion strategies. The dominant share is attributed to high investment in the biotechnology sector and its increasing adoption in cancer research and the development of new biologics, vaccines, and drugs. Moreover, the increasing number of R&D investments initiated by the companies is one of the key potential growth factors responsible for the sizeable share garnered by North America. Furthermore, the increasing chronic disease burden in this region is anticipated to drive the use of advanced technologies amongst researchers and healthcare professionals, which is further anticipated to widen the scope for growth.

In North America, the US had the largest market share. The aforementioned factor is a significant contributing factor enabling wide-scale drug development and subsequent commercialization by major biopharmaceutical companies across this region. This is further believed to engender a greater need to ensure high safety standards for specialized and targeted therapies and avert probable shortcomings. Moreover, healthcare organizations, such as the U.S. FDA, and U.S. Department of Health and Human Services, in collaboration with the Centers for Disease Control and Prevention and National Institutes of Health, consistently strive to improve the biological and microbiological safety testing standards for biomedical laboratories through the formulation and enforcement of stringent regulatory guidelines.

Browse complete report: https://www.marketstatsville.com/biological-safety-testing-market

This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the biological safety testing market. It also consists of the profiles of leading companies such as Eurofins Scientific, Lonza, Merck KGaA, Promega Corporation, Thermo Fisher Scientific, Avance Biosciences, Cytovance Biologics, Toxikon, WuXi AppTec, and Biomerieux SA.

Related Reports:

Novel Vaccine Delivery System Market - https://www.marketstatsville.com/novel-vaccine-delivery-system-market

Lysosomal Storage Disease Treatment Market - https://www.marketstatsville.com/lysosomal-storage-disease-treatment-market

Contact US:
Eric Martin
800 Third Avenue Suite A #1519
New York, NY 10022
+1 (646) 663-5829 | India: +91-702-496-8807
Email: sales@marketstatsville.com
MSG Blog https://marketstatsvilleblogs.com/
Web: https://marketstatsville.com/

About US:
Market Statsville Group (MSG) partners with companies and society to confront their essential risks and challenges to capture the enormous opportunities for them. MSG initiated its work in 2017, and since then, the brand is moving to become a pioneer in business advisory and market research services.
We the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and incisive business insights. MSG experienced research analysts are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact.

This release was published on openPR.